SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following the announcement of a private debt exchange that will reduce long-term obligations by converting notes into equity, a move that has sparked intense debate among retail investors regarding potential dilution versus long-term balance sheet strengthening. The community remains deeply divided, with some users speculating the move is a strategic precursor to a major acquisition, while others express frustration over management's capital allocation and the impact on share value.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investors bet on a potential short squeeze fueled by an exceptionally high short interest relative to the float and bullish sentiment surrounding the company's expansion into AI infrastructure through its acquisition of Northern Data. The community is intensely debating the stock's valuation as a data center and compute-heavy AI play while tracking upcoming earnings and the potential impact of strategic partnerships on the firm's cloud revenue.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is surging toward all-time highs as a massive short squeeze unfolds, fueled by market optimism surrounding potential diplomatic talks with Iran and coordinated currency interventions. Community members are actively debating the sustainability of this aggressive melt-up, with many traders questioning the validity of the underlying news catalysts while bulls remain focused on the strength of recent momentum.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is attracting significant attention as investors react to a combination of strong commercial momentum for its MS franchise and persistent short interest, fueling active community debate regarding a potential buyout or long-term valuation expansion. Despite volatility, proponents remain focused on the companys upcoming subcutaneous program and potential label expansions in secondary indications as key catalysts for future growth.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is facing intense investor speculation as the community eagerly anticipates Phase 3 IZAR-1 trial results, with sentiment split between confidence in 'best-in-class' outcomes and frustration over the delayed timeline. Active discussions focus on interpreting management's 'about a month' guidance, the potential for a transformative partnership or buyout, and the impact of heavy institutional ownership on current price volatility.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is facing significant downward pressure and setting new lows as the market rotates out of high-growth names, leading the community to debate whether current prices represent a generational buying opportunity or a deeper fundamental decline. Investors remain sharply divided, with bulls pointing to historical buyback potential and strong brand momentum while bears cite increasing competitive headwinds and margin pressures ahead of the upcoming earnings release.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending as investors react to the FAA's certification of the 737 MAX-7, a long-awaited milestone that serves as a key catalyst for potential delivery momentum and cash flow recovery. The community is actively debating whether this certification signals a sustained turnaround for the companys broader aircraft backlog or if the stock will continue to face volatility from ongoing execution challenges and defense-related cost pressures.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is currently trending as investors brace for the upcoming earnings call, with community sentiment deeply polarized between frustration over stagnant share price performance and optimism surrounding the potential for proprietary Matrix-M licensing deals. The discussion is heavily focused on the company's strategic pivot toward a leaner licensing model, with many participants intensely scrutinizing management's communication and the long-term value of their combination vaccine pipeline.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp (UAMY) is trending as retail investors rally behind the stock, viewing recent federal executive orders and defense-related supply chain mandates as major catalysts for the critical minerals sector. While community members debate whether current price action is being driven by institutional manipulation or a fundamental turnaround in defense demand, many are actively discussing the stock's role as a sole-source domestic provider for military-grade antimony.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending due to a surge in positive sentiment following recent record-breaking ABS deal closures and signals of improved profitability. Community discourse focuses on the stock's significant discount relative to fintech peers, with investors actively discussing potential analyst price target upgrades and a possible short squeeze as the company approaches its upcoming earnings report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AMRX Down Despite Q2 Earnings Beat, 2026 Revenue Outlook Raised

Amneal tops second-quarter earnings and revenue estimates and lifts its 2026 outlook.

Compared to Estimates, Amneal (AMRX) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Amneal (AMRX) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Amneal Pharmaceuticals (AMRX) Q2 Earnings and Revenues Surpass Estimates

Amneal (AMRX) delivered earnings and revenue surprises of +25.00% and +3.70%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Amneal Pharmaceuticals, Inc. Q2 Profit Advances

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) released earnings for its second quarter that Increases, from last year...

Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm

Kaskela Law is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (Amneal) on behalf of the companys current shareholders. The investigation seeks to determine whether Amneal or the companys officers and/or directors violated the securities laws or breached their fiduciary duties in...

Here's Why Amneal Pharmaceuticals (AMRX) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why Amneal Pharmaceuticals (AMRX) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Korro Bio, Inc. (KRRO) Soars 17.6%: Is Further Upside Left in the Stock?

Korro Bio, Inc. (KRRO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Is Amarin (AMRN) Outperforming Other Medical Stocks This Year?

Here is how Amarin (AMRN) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector so far this year.

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

Amneal Pharma Stock Rises On FDA Approval For Generic Version Of AbbVie’s Eyedrops

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

AMRXAmneal Pharmaceuticals Inc - Ordinary Shares - Class A

Fundamentals

Connect Stocktwits to ChatGPT

Latest AMRX News